$CNOB Cashflow Statement | Understand Stock

$CNOB

$32.99 +$0.15 (0.46%) Close

$CNOB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
(Reversal) of provision for credit losses
Depreciation and amortization of premises and equipment
Provision for credit losses
Amortization of intangibles
Net accretion of loans
Accretion on bank premises
Amortization (accretion) on deposits
(Accretion) amortization on borrowings
Amortization on borrowings
Loss on bank owned life insurance policy exchange
Stock-based compensation
Losses (gains) on sales/redemptions of investment securities, net
Gains (losses) on sale of loans held-for-sale, net
Gains on sales/redemptions of investment securities, net
(Gain) loss on equity securities, net
Gain on sale of loans held-for-sale, net
Gain on sale of branches
Loans originated for resale
Proceeds from sale of loans held-for-sale
Net loss on disposition of fixed assets
Net loss on sale of other real estate owned
Accretion of cash surrender value of bank owned life insurance
Accretion of discounts and amortization of premium on securities available-for-sale
Amortization of subordinated debt issuance costs
(Increase) decrease in accrued interest receivable
Net change in operating leases
(Increase) decrease in other assets
Increase (decrease) in other liabilities
Net cash provided by operating activities

Cash flows from investing activities
Purchases
Sales
Maturities, calls and principal repayments
Purchases of equity securities
Proceeds from equity securities sold
Net redemptions (purchases) of restricted investment in bank stocks
Loans held-for-sale payments
Net (increase) decrease in loans
Cash flow hedge premium payment
Proceeds from sale of other real estate owned
Proceeds from bank owned life insurance
Purchases of premises and equipment
Purchases of bank owned life insurance
Proceeds from disposition of fixed assets
Proceeds from sale of branches
Cash and cash equivalents acquired in acquisitions, net
Cash acquired, net of cash consideration paid in acquisition
Net cash (used in) provided by investing activities

Cash flows from financing activities
Net increase in deposits
Advances of FHLB borrowings
Repayments of FHLB borrowings
Proceeds from issuance of subordinated debt
Redemption of subordinated debt
Payment of subordinated debt issuance costs
Proceeds from FHLB borrowings
Repayment of FHLB borrowings
Cash dividends paid on preferred stock
Cash dividends paid on common stock
Proceeds from preferred stock offering
Purchase of treasury stock
Proceeds from exercise of stock options
Share redemption for tax withholdings on performance units and restricted stock units earned
Share redemption for tax withholdings on performance units and deferred stock units earned
Net cash provided by (used in) financing activities
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Supplemental disclosures of cash flow information:
Interest paid
Income taxes paid
Supplemental disclosures of noncash investing activities:
Transfer of loans to other real estate owned
Fair value of assets acquired
Fair value of liabilities assumed
Stock issued in connection with FLIC merger
Transfer of loans held-for-sale to loans held-for-investment
Transfer of loans held-for-investment to loans held-for-sale

Comments